ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0130

Three Chinese Pedigrees of A20 Haploinsufficiency

Yi Tian1, Min Shen2, Bingxuan Wu2, linyi Peng2 and Jian Wang3, 1Rheumatology Department, The Second Affiliated Hospital of Dalian Medical University, Dalian, China, 2Department of Rheumatology, Peking Union Medical College Hospital, Beijing, China, 3Jinzhou City Center for Disease Control and Prevention, Jinzhou, China

Meeting: ACR Convergence 2022

Keywords: Autoinflammatory diseases, Miscellaneous Rheumatic and Inflammatory Diseases

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Haploinsufficiency of A20 (HA20) is a newly described rare autoinflammatory disease caused by TNFAIP3 gene mutations. HA20 has been seldom documented in the Chinese population. Herein, we reported eight patients with HA20 from three unrelated families in China.

Methods: Eight Chinese Han patients were diagnosed with HA20 in our department from 2018 to 2021. Their clinical data and genotype were carefully documented and studied. The newly identified variants were functionally verified. We also conducted a systematic literature review about HA20, and the clinical characteristics and genotype of HA20 between the Chinese population and other populations were compared.

Results: Eight HA20 patients from three families comprised of six adults and two children. There were 1 man and 7 women. Family pedigrees, clinical manifestations, and gene sequencing of HA20 patients were shown in Fig 1. The clinical characteristics included recurrent oral ulcers (8/8, 100%), fever (5/8, 63%), perianal ulcer (3/8, 38%), skin lesions (2/8, 25%), arthritis (1/8, 13%), and uveitis (1/8, 13%). Three TNFAIP3 variants, A547T, c.1906+2T >G, and R271*, were identified. Two novel variants, A547T and c.1906+2T >G, were validated to be pathogenic in our study (Fig 2). Through literature review, a total of 126 patients with HA20 reported by 35 articles were included. The clinical phenotype of Chinese HA20 patients was similar to that of patients from other populations except for a lower frequency of genital ulcers (16.7% vs. 54.4%, p< 0.01). Autoantibodies were detectable in about one-third of the 126 patients, among which ANA and anti-thyroid antibodies were commonly seen.

Conclusion: The rarity and diversity of phenotype make the diagnosis of HA20 a huge challenge to physicians. HA20 should be considered in child-onset patients with manifestations that resemble Behçet’s syndrome, especially those whose family members have similar symptoms. Gene testing is critically helpful for the diagnosis of HA20. Two novel TNFAIP3 variants, A547T and c.1906+2T >G, have been identified in this study.

Supporting image 1

Fig 1. Family pedigrees, clinical manifestations, and gene sequencing of HA20 patients. A: Pedigree analysis of Family 1. B: Erythema nodosa of P1 (V:24). C: Whole-exome sequencing by Next Generation Sequencing of Family 1, showing the heterozygous TNFAIP3 (NM_006290.4): c.1639G>A, p.A547T variant. D: Pedigree analysis of Family 2. E: Gene sequencing of Family 2, showing TNFAIP3 c.1906+2T>G heterozygous variant in P2 (III:5) and her daughter (IV:1). F: Pedigree analysis of Family 3. P: proband; (+/-): Heterozygous variants; (-/-): Wild type; (NA): Undetected.

Supporting image 2

Fig 2. Pathogenicity validation of novel TNFAIP3 variants. A: The predicted 3D structure of wild type (WT) and A547T variant of A20 protein. B: Schematic view of Complementary DNA analysis of WT and the splice site mutation c.1906+2T>G. C: Agarose gel electrophoresis result. P2, the proband of the second family; Ctrl, healthy controls. D: Western blot analysis of A20 expression, NF-κB and NLRP3 inflammasome signaling pathway in PBMCs from P2 and controls. E: Cytokine (TNF-α, IL-6 and IL_1β) levels in plasma and culture supernatants of PBMCs from P2 and controls (mean ± SD from three independent experiments in P2 and n=3 controls, P values were determined by unpaired two-tailed Student’s t-test).

Supporting image 3

Fig 3. A: Comparison of clinical phenotypes of HA20 patients in China and other populations. *: P<0.05. B: The locations of variants in the TNFAIP3 gene. The red arrows represent the locus of variants in the Chinese (20). The orange arrows represent the locus of variants from other populations (41). The purple boxes represent co-owned variants (4).


Disclosures: Y. Tian, None; M. Shen, None; B. Wu, None; l. Peng, None; J. Wang, None.

To cite this abstract in AMA style:

Tian Y, Shen M, Wu B, Peng l, Wang J. Three Chinese Pedigrees of A20 Haploinsufficiency [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/three-chinese-pedigrees-of-a20-haploinsufficiency/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/three-chinese-pedigrees-of-a20-haploinsufficiency/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology